Latin American Virtual Regional

NANETS Phili

NANETS Regional NET Education: Latin American Virtual Regional

February 11, 2023

11:00am – 4:40pm EST

Register Here


Platform

Virtual Event will be hosted over the Zoom platform

Course Directors

Dr. Juan Manuel O’Connor from the Alexander Fleming Institute in Buenos Aires, Argentina
Dr. Daniel Bulzico from the National Cancer Institute in Rio de Janeiro, Brazil
Dr. Paola Jimenez Vasquez from the Center for Research and Treatment in Cancer
"Luis Carlos Sarmiento Angulo FCTIC" in Bogota, Colombia
Dr. Alan Burguete-Torres from the University of Nuevo Leon Cancer Center in Monterrey, Mexico

Overview

The North American Neuroendocrine Tumor Society (NANETS) is pleased to invite you to attend the first Latin American NANETS virtual regional meeting, where medical professionals from North and South America will come together to share and learn about the treatment and management of neuroendocrine tumor disease.

This initiative is the result of three years of intense work guided by the Diversity and Membership Committee under the successive Chairmanships of Dr. Pamela Kunz, Yale University (2020), Dr. Camilo Jimenez, The University of Texas MD Anderson Cancer Center (2021), Dr. Namrata Vijayvergia, Fox Chase Cancer Center (2022), and Dr. Bryson Katona, University of Pennsylvania (2023), and with the support of Dr. Jaydira del Rivero from the National Cancer Institute. This initiative was approved by the prior Presidents of the NANETS, Dr. Emily Bergsland, Stanford University (2021), and Dr. Jonathan Strosberg, University of South Florida H. Lee Moffit Cancer Center (2022), and is strongly supported by our newly elected President, Dr. Pamela Kunz.

The present program has been developed in collaboration with experts and representatives of four different countries in Latin America, including Dr. Juan Manuel O’Connor from the Alexander Fleming Institute in Buenos Aires, Argentina, Dr. Daniel Bulzico from the National Cancer Institute in Rio de Janeiro, Brazil, Dr. Paola Jimenez from the Center for Research and Treatment in Cancer "Luis Carlos Sarmiento Angulo FCTIC" in Bogota, Colombia, and Dr. Alan Burguete from the University of Nuevo Leon Cancer Center in Monterrey, Mexico.

Speakers from Argentina, Brazil, Canada, Colombia, Mexico, Puerto Rico, and the United States of America will discuss controversial aspects of a variety of treatment approaches for patients with neuroendocrine tumors. Dr. Thor Halfdanarson from the Mayo Clinic will deliver the Keynote address on “Precision Medicine in Neuroendocrine Tumors.” During this course, participants will learn how to diagnose and treat NETs, hear about ongoing research on neuroendocrine tumors, and have opportunities to hear perspectives from clinicians throughout the Americas. In addition to allowing the establishment of networking and collaborations, this meeting will be the first of many anticipated joint efforts between NANETS and Latin America.

Target Audience

This activity is designed for oncologists, gastroenterologists, pulmonologists, surgeons, radiologists, pathologists, primary care physicians, advanced practice nurses, nurses, physician assistants, pharmacists, fellows, students, and other allied health professionals involved with or interested in the treatment of patients with neuroendocrine tumors.

Program

11:00-11:10 am
Welcome and Opening Remarks
    • Overview of NANETS
      Pamela Kunz, MD, Yale School of Medicine
    • Presenting The LATAM NANETS Initiative
      Camilo Jimenez, MD, The University of Texas, MD Anderson Cancer Center
11:10 am-12:35 pm
Controversies in Medical Therapy - WDNET
    • Small Intestine Case: Carcinoid Syndrome
      Dr. Rachel Simões Pimenta Riechelmann, AC Camargo Cancer Center, São Paulo, Brazil
      Dr. Marianna Bruno Siquiera, Instituto D'or de Pesquisa e Ensino in Rio de Janeiro, Brazil
    • Thoracic NET
      Dr. Paola Jiménez Vásquez, Center for Research and Treatment of Cancer "Luis Carlos Sarmiento Angulo FCTIC", Bogotá, Colombia
      Dr. Leonardo Rojas, Xaverian University in Bogota, Colombia
    • Management of Functional NETs
      Dr. Daniel Bulzico, Instituto Nacional de Câncer, Rio de Janeiro, Brazil
12:35-1:30 pm
Controversies in Medical Therapy - PDNET
    • Case 1: NET G3 Páncreas
      Dr. Alan Burguete-Torres, Hospital Zambrano, San Pedro Garza García, N.L.
    • Case 2: PDNEC
      Dr. Juan Manuel O'Connor, Institute Alexander Fleming, Buenos Aires
1:30-1:50 pm
Break
1:50-3:20 pm
Controversies in NET Surgery
    • Resection of the Primary Tumor in Stage IV Disease SB and PNET?
      Alexandra Gangi, MD, Cedars-Sinai 
    • Surgery for PNET < 2cm, yes or no?
      Callisia N Clarke, MD, MS, FACS, FSSO, Medical College of Wisconsin
    • Hepatic Cytoreductive Surgery; Is there a Limit?
      Daniel Anaya Saenz, MD, Moffitt Cancer Center 
    • Indications of Liver Transplant: Pros and Cons
      Julie Hallet, MD, MSC FRCSC, Odette Cancer Centre at the Sunnybrook Health Sciences Centre
    • Is there a Role for Neoadjuvant or Adjuvant Therapy?
      Heloisa P. Soares, MD, PhD, University of Utah Health
3:20 – 3:50 pm
Overview of Precision Medicine in Neuroendocrine Tumors: Ready for Prime Time?
    • Thorvardur (Thor) R. Halfdanarson, MD, Mayo Clinic
3:50-4:30 pm
Panel Discussions
    • Overview of Current Local NET Care Scenario
      Argentina: Dr. Juan Manuel O Connor
      Brazil: Dr. Daniel Bulzico
      Colombia: Dr. Paola Jiménez Vásquez
      Mexico: Dr. Alan Burguete-Torres
    • Perspectives of Collaborative Work
      Argentina: Dr. Juan Manuel O Connor
      Brazil: Dr. Daniel Bulzico
      Colombia: Dr. Paola Jiménez Vásquez
      Mexico: Dr. Alan Burguete-Torres
      USA: Dr. Camilo Jimenez
      USA: Dr. Namrata (Neena) Vijayvergia
      USA: Dr. Jaydira del Rivero
      USA: Dr. Sarimar Agosto Salgado
4:30-4:40 pm
Final Considerations

 

Registration Fee:

This event is free and open to all medical professionals

Register Here 

Questions?

Please contact us with any questions.